vs
ADAMAS TRUST, INC.（ADAM）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是ADAMAS TRUST, INC.的1.7倍（$75.5M vs $43.2M），ADAMAS TRUST, INC.同比增速更快（61.6% vs 27.7%），ADAMAS TRUST, INC.自由现金流更多（$125.9M vs $14.4M），过去两年ADAMAS TRUST, INC.的营收复合增速更高（55.5% vs 31.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ADAM vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$43.2M
营收增速更快
ADAM
高出33.9%
27.7%
自由现金流更多
ADAM
多$111.5M
$14.4M
两年增速更快
ADAM
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $43.2M | $75.5M |
| 净利润 | $53.5M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 124.0% | — |
| 营收同比 | 61.6% | 27.7% |
| 净利润同比 | 270.5% | — |
| 每股收益（稀释后） | $0.45 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADAMPBYI
| Q4 25 | $43.2M | $75.5M | ||
| Q3 25 | $36.6M | $54.5M | ||
| Q2 25 | $36.4M | $52.4M | ||
| Q1 25 | $33.1M | $46.0M | ||
| Q4 24 | $26.7M | $59.1M | ||
| Q3 24 | $20.2M | $80.5M | ||
| Q2 24 | $19.0M | $47.1M | ||
| Q1 24 | $17.9M | $43.8M |
净利润ADAMPBYI
| Q4 25 | $53.5M | — | ||
| Q3 25 | $44.8M | $8.8M | ||
| Q2 25 | $8.5M | $5.9M | ||
| Q1 25 | $42.2M | $3.0M | ||
| Q4 24 | $-31.4M | — | ||
| Q3 24 | $42.8M | $20.3M | ||
| Q2 24 | $-15.6M | $-4.5M | ||
| Q1 24 | $-57.9M | $-4.8M |
毛利率ADAMPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率ADAMPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | 11.7% | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | -119.0% | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | -124.7% | -4.6% | ||
| Q1 24 | -448.8% | -5.3% |
净利率ADAMPBYI
| Q4 25 | 124.0% | — | ||
| Q3 25 | 122.5% | 16.2% | ||
| Q2 25 | 23.4% | 11.2% | ||
| Q1 25 | 127.4% | 6.5% | ||
| Q4 24 | -117.5% | — | ||
| Q3 24 | 211.7% | 25.2% | ||
| Q2 24 | -81.9% | -9.6% | ||
| Q1 24 | -324.1% | -11.0% |
每股收益（稀释后）ADAMPBYI
| Q4 25 | $0.45 | $0.26 | ||
| Q3 25 | $0.36 | $0.17 | ||
| Q2 25 | $-0.04 | $0.12 | ||
| Q1 25 | $0.33 | $0.06 | ||
| Q4 24 | $-0.46 | $0.40 | ||
| Q3 24 | $0.36 | $0.41 | ||
| Q2 24 | $-0.29 | $-0.09 | ||
| Q1 24 | $-0.75 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $210.3M | $97.5M |
| 总债务越低越好 | $735.8M | $22.7M |
| 股东权益账面价值 | $1.4B | $130.3M |
| 总资产 | $12.6B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.52× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ADAMPBYI
| Q4 25 | $210.3M | $97.5M | ||
| Q3 25 | $185.3M | $94.4M | ||
| Q2 25 | $160.4M | $96.0M | ||
| Q1 25 | $177.1M | $93.2M | ||
| Q4 24 | $167.4M | $101.0M | ||
| Q3 24 | $195.1M | $96.7M | ||
| Q2 24 | $235.5M | $96.8M | ||
| Q1 24 | $226.9M | $107.2M |
总债务ADAMPBYI
| Q4 25 | $735.8M | $22.7M | ||
| Q3 25 | $766.6M | $34.0M | ||
| Q2 25 | $653.0M | $45.3M | ||
| Q1 25 | $654.4M | $56.7M | ||
| Q4 24 | $573.2M | $68.0M | ||
| Q3 24 | $699.4M | $79.3M | ||
| Q2 24 | $800.7M | $90.7M | ||
| Q1 24 | $1.0B | $102.0M |
股东权益ADAMPBYI
| Q4 25 | $1.4B | $130.3M | ||
| Q3 25 | $1.4B | $115.3M | ||
| Q2 25 | $1.4B | $104.7M | ||
| Q1 25 | $1.4B | $97.1M | ||
| Q4 24 | $1.4B | $92.1M | ||
| Q3 24 | $1.4B | $71.1M | ||
| Q2 24 | $1.4B | $48.5M | ||
| Q1 24 | $1.5B | $51.0M |
总资产ADAMPBYI
| Q4 25 | $12.6B | $216.3M | ||
| Q3 25 | $12.4B | $202.9M | ||
| Q2 25 | $10.6B | $194.9M | ||
| Q1 25 | $10.0B | $196.2M | ||
| Q4 24 | $9.2B | $213.3M | ||
| Q3 24 | $8.9B | $220.7M | ||
| Q2 24 | $8.2B | $205.0M | ||
| Q1 24 | $7.4B | $214.1M |
负债/权益比ADAMPBYI
| Q4 25 | 0.52× | 0.17× | ||
| Q3 25 | 0.55× | 0.30× | ||
| Q2 25 | 0.47× | 0.43× | ||
| Q1 25 | 0.47× | 0.58× | ||
| Q4 24 | 0.41× | 0.74× | ||
| Q3 24 | 0.48× | 1.12× | ||
| Q2 24 | 0.56× | 1.87× | ||
| Q1 24 | 0.67× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $134.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $125.9M | $14.4M |
| 自由现金流率自由现金流/营收 | 291.6% | 19.1% |
| 资本支出强度资本支出/营收 | 18.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.50× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流ADAMPBYI
| Q4 25 | $134.0M | $14.4M | ||
| Q3 25 | $6.9M | $9.7M | ||
| Q2 25 | $39.2M | $14.1M | ||
| Q1 25 | $25.8M | $3.6M | ||
| Q4 24 | $14.1M | $15.6M | ||
| Q3 24 | $-922.0K | $11.0M | ||
| Q2 24 | $-993.0K | $1.0M | ||
| Q1 24 | $-13.1M | $11.2M |
自由现金流ADAMPBYI
| Q4 25 | $125.9M | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $-10.6M | $15.6M | ||
| Q3 24 | $-8.6M | $11.0M | ||
| Q2 24 | $-8.6M | $1.0M | ||
| Q1 24 | $-19.1M | — |
自由现金流率ADAMPBYI
| Q4 25 | 291.6% | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | -39.6% | 26.4% | ||
| Q3 24 | -42.3% | 13.7% | ||
| Q2 24 | -44.9% | 2.1% | ||
| Q1 24 | -107.0% | — |
资本支出强度ADAMPBYI
| Q4 25 | 18.9% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 92.3% | 0.0% | ||
| Q3 24 | 37.7% | 0.0% | ||
| Q2 24 | 39.7% | 0.0% | ||
| Q1 24 | 33.5% | 0.0% |
现金转化率ADAMPBYI
| Q4 25 | 2.50× | — | ||
| Q3 25 | 0.15× | 1.10× | ||
| Q2 25 | 4.59× | 2.41× | ||
| Q1 25 | 0.61× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.02× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADAM
| Other | $19.6M | 45% |
| Constructive Loans LLC | $14.4M | 33% |
| Multifamily | $9.1M | 21% |
PBYI
暂无分部数据
